Latest liver transplant Stories
LOS ANGELES, Feb.
Living liver donors share their stories -- more step forward to donate.
Life-saving therapeutic interventions possible with early detection of hepatitis C recurrence.
Extending hepatitis C treatment for liver transplant patients beyond current practice results in high rates of clearance of the hepatitis C virus from the blood, as well as a low rate of relapse, according to a Henry Ford Hospital study.
According to the Centers for Disease Control and Prevention (CDC) 1.5 to 2 million Americans are infected with the hepatitis B virus (HBV).
Deterioration of renal function with CNI therapy has been widely reported in liver transplant recipients. Microproteinuria has been used to monitor the early changes of nephropathy in renal disease or cardiovascular events.
New Orleans' Ochsner Medical Center Offers Short Wait Times & High Survival for Liver Transplants NEW ORLEANS, June 23 /PRNewswire/ -- (www.ochsner.org/transplant) - It's a little known fact that California resident and Founder/CEO of Apple, Inc., Steve Jobs, has brought to light: patients in need of transplants can be added to waiting lists in other states.
Two new studies address donor factors that could affect outcomes for liver transplant recipients, particularly those with chronic hepatitis C (HCV).
A British-led study has determined survival rates among HIV positive and HIV negative patients are similar following liver transplantations. The research led by Kosh Agarwal at the Institute of Liver Studies at Kings College Hospital in London showed no difference in survival rates at one and five years between HIV negative and HIV positive patients, suggesting a good prognosis for HIV positive patients following liver transplant. However, the researchers said their findings confirmed...
A recent scientific discovery could reduce liver damage and prevent deaths caused by paracetamol overdoses.
- A political dynamiter.